// App-Quantinova.ai

DXT55 : Severity and Frequency of Relapses in Patients with Relapsing-Remitting MS Treated with Cladribine Tablets in Clarity and Placebo in Clarity Extension

Researchers

Presenter

  • Sven Schippling

Principal Investigators

  • Maria Pia Sormani

  • Nicola De Stefano

  • Gavin Giovannoni

  • Fernando Dangond

  • Andrew Galazka

  • Birgit Keller

  • Nektaria Alexandri

Medical Centers

  • University of Genoa

  • Queen Mary University of London and Blizard Institute Barts and The London School of Medicine and Dentistry London United Kingdom

  • 6Neuroimmunology and Multiple Sclerosis Research, University Hospital Zürich and University of Zürich Zürich Switzerland

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Cladribine

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • NCT00213135

  • NCT00641537

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved